25-Oct-2024 4:00 PM CST - Business Wire National Research Corporation Announces Third Quarter Results National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the third quarter 2024 and other corporate developments. Financial Results Revenue for the quarter was approximately $35.8 million compared with approximately $37.9 million in the 2023 quarter. Earnings per diluted share were $0.24 compared with $0.32 for the 2023 quarter. At September 30, 2024, the Companys net indebtedness (total borrowing minus cash and cash equivalents) w
25-Oct-2024 4:00 PM CST - Business Wire National Research Corporation Announces Third Quarter Results National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the third quarter 2024 and other corporate developments. Financial Results Revenue for the quarter was approximately $35.8 million compared with approximately $37.9 million in the 2023 quarter. Earnings per diluted share were $0.24 compared with $0.32 for the 2023 quarter. At September 30, 2024, the Companys net indebtedness (total borrowing minus cash and cash equivalents) w
